Monday, 25 August 2014

Fancy that - Roche agrees to buy InterMune for $8.3 billion

Good evening Betavillers!

I would have posted yesterday but I was taking a day off, enjoying the Notting Hill Carnival (for international readers unfamiliar with the Notting Hill Carnival, it is one of the biggest street parties in Europe held in the area of London where I live).

Anyway, I'm sure most of you have noticed that Switzerland-based Roche has agreed to buy US biopharmaceutical company InterMune for $8.3 billion.

I would just like to point out that little old Betaville first reported that several of Europe's largest pharmaceutical companies, including Roche, were interested in buying InterMune back in April and followed that story up with several updates.

Here are the links to those pieces:

No comments:

Post a Comment